Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multi-target therapeutics for neuropsychiatric and neurodegenerative disorders
Priya Bawa, Priyamvada Pradeep, Pradeep Kumar, et al.
Drug Discovery Today (2016) Vol. 21, Iss. 12, pp. 1886-1914
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Neuroinflammation Induces Neurodegeneration.
Duraisamy Kempuraj, Ramasamy Thangavel, Prashant Natteru, et al.
PubMed (2016) Vol. 1, Iss. 1
Closed Access | Times Cited: 587
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
Ewgenij Proschak, Holger Stark, Daniel Merk
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 2, pp. 420-444
Closed Access | Times Cited: 410
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
Junting Zhou, Xueyang Jiang, Siyu He, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 20, pp. 8881-8914
Closed Access | Times Cited: 232
Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains
Christian Haenig, Nir Atias, Alexander K. Taylor, et al.
Cell Reports (2020) Vol. 32, Iss. 7, pp. 108050-108050
Open Access | Times Cited: 89
Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities
Damijan Knez, Nicolas Coquelle, Anja Pišlar, et al.
European Journal of Medicinal Chemistry (2018) Vol. 156, pp. 598-617
Closed Access | Times Cited: 82
Multi-Target Approach for Drug Discovery against Schizophrenia
Magda Kondej, Piotr Stępnicki, Agnieszka A. Kaczor
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 3105-3105
Open Access | Times Cited: 79
Network Pharmacology and Bioinformatics Approach Reveals the Therapeutic Mechanism of Action of Baicalein in Hepatocellular Carcinoma
Chongyang Ma, Tian Xu, Xiaoguang Sun, et al.
Evidence-based Complementary and Alternative Medicine (2019) Vol. 2019, pp. 1-15
Open Access | Times Cited: 52
Dual Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer’S Disease
Damijan Knez, Matej Sova, Urban Košak, et al.
Future Medicinal Chemistry (2017) Vol. 9, Iss. 8, pp. 811-832
Closed Access | Times Cited: 50
Neuroprotective effects of oleuropein: Recent developments and contemporary research
Masood Sadiq Butt, Urwa Tariq, Iahtisham Ul-Haq, et al.
Journal of Food Biochemistry (2021) Vol. 45, Iss. 12
Open Access | Times Cited: 39
RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist
Bryan Oronsky, Lori H. Takahashi, Richard D. Gordon, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 15
Network Analysis of Drug–target Interactions: A Study on FDA-approved New Molecular Entities Between 2000 to 2015
Hui-Heng Lin, Lele Zhang, Ru Yan, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 42
High‐throughput screening assays for SARS‐CoV‐2 drug development: Current status and future directions
Tuan Xu, Wei Zheng, Ruili Huang
Drug Discovery Today (2021) Vol. 26, Iss. 10, pp. 2439-2444
Open Access | Times Cited: 28
Recent Developments in Coumarin Derivatives as Neuroprotective Agents
Prakash Shyambabu Mishra, Amit Kumar, Kamalpreet Kaur, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 35, pp. 5702-5738
Closed Access | Times Cited: 12
Drug discovery and computational strategies in the multitarget drugs era
Jéssika de Oliveira Viana, Mayara Barbalho Félix, Mayara dos Santos Maia, et al.
Brazilian Journal of Pharmaceutical Sciences (2018) Vol. 54, Iss. spe
Open Access | Times Cited: 35
Rational Design of Novel Selective Dual-Target Inhibitors of Acetylcholinesterase and Monoamine Oxidase B as Potential Anti-Alzheimer’s Disease Agents
Yixiang Xu, Jian Zhang, Huan Wang, et al.
ACS Chemical Neuroscience (2018) Vol. 10, Iss. 1, pp. 482-496
Closed Access | Times Cited: 34
The impact of the halogen bonding on D 2 and 5-HT 1A /5-HT 7 receptor activity of azinesulfonamides of 4-[(2-ethyl)piperidinyl-1-yl]phenylpiperazines with antipsychotic and antidepressant properties
Anna Partyka, Rafał Kurczab, Vittorio Canale, et al.
Bioorganic & Medicinal Chemistry (2017) Vol. 25, Iss. 14, pp. 3638-3648
Closed Access | Times Cited: 28
Chemoinformatic Database Building and in Silico Hit-Identification of Potential Multi-Targeting Bioactive Compounds Extracted from Mushroom Species
Annalisa Maruca, Federica Moraca, Roberta Rocca, et al.
Molecules (2017) Vol. 22, Iss. 9, pp. 1571-1571
Open Access | Times Cited: 26
Natural products, an important resource for discovery of <br />multitarget drugs and functional food for regulation of hepatic glucose metabolism
Jian Li, Haiyang Yu, Sijian Wang, et al.
Drug Design Development and Therapy (2018) Vol. Volume 12, pp. 121-135
Open Access | Times Cited: 25
Druggable targets from coronaviruses for designing new antiviral drugs
Leandro Rocha Silva, Paulo Fernando da Silva Santos-Júnior, Júlia de Andrade Brandão, et al.
Bioorganic & Medicinal Chemistry (2020) Vol. 28, Iss. 22, pp. 115745-115745
Open Access | Times Cited: 22
Design, synthesis and evaluation of vilazodone-tacrine hybrids as multitarget-directed ligands against depression with cognitive impairment
Wenwen Liu, Huan Wang, Xiaokang Li, et al.
Bioorganic & Medicinal Chemistry (2018) Vol. 26, Iss. 12, pp. 3117-3125
Closed Access | Times Cited: 22
Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapy
Fernanda S. Tonin, Astrid Wiens, Fernando Fernández-Llimós, et al.
Core evidence (2016) Vol. Volume 11, pp. 49-61
Open Access | Times Cited: 20
Frameworking memory and serotonergic markers
Alfredo Meneses
Reviews in the Neurosciences (2017) Vol. 28, Iss. 5, pp. 455-497
Closed Access | Times Cited: 18
Design, synthesis and biological evaluation of novel c-Met/HDAC dual inhibitors
Yuhong Dong, Hao Hu, Yuwei Sun, et al.
Bioorganic & Medicinal Chemistry Letters (2020) Vol. 30, Iss. 23, pp. 127610-127610
Closed Access | Times Cited: 15
The novel therapeutic strategy of vilazodone-donepezil chimeras as potent triple-target ligands for the potential treatment of Alzheimer's disease with comorbid depression
Xiaokang Li, Jinwen Li, Yunyuan Huang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 229, pp. 114045-114045
Closed Access | Times Cited: 13
Hybrid molecules of scutellarein and tertramethylpyrazine’s active metabolites for ischemic stroke
Yongxi Dong, Xiaohe Zhang, Mingji Liu, et al.
Bioorganic & Medicinal Chemistry Letters (2019) Vol. 29, Iss. 19, pp. 126608-126608
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top